Figure 2
Risk of cancers in patients with type 2 diabetes who were treated with DPP-4 inhibitors versus other drugs. DPP4i: dipeptidyl peptidase-4 inhibitors.
Figure 2 | Scientific Reports
Risk of cancers in patients with type 2 diabetes who were treated with DPP-4 inhibitors versus other drugs. DPP4i: dipeptidyl peptidase-4 inhibitors.
